Peter Mueller, EVP, Global R&D, CSO at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,500 shares at $53.84 ($352K) on 2012-08-15, disclosed to the SEC on 2012-08-17.
Scheduled sale ($352k) by EVP, Global R&D, CSO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $53.84 | 2,400 | $129K | 36.7% |
| 2 | $54.30 | 4,100 | $223K | 63.3% |
| Total | $54.13 avg | 6,500 | $352K | 100% |
| Filing → |
| BTAI | BUY | 2018-12-07 | $44K | — | Filing → |
| BTAI | BUY | 2018-12-06 | $21K | — | Filing → |
| VRTX | SELL | 2014-06-18 | $512K | — | Filing → |